Successful combination therapy with acyclovir and vidarabine for disseminated varicella zoster virus infection with retinal involvement in a patient with B-cell lymphoma and adult T-cell leukemia

1988 ◽  
Vol 85 (6) ◽  
pp. 885-886 ◽  
Author(s):  
Kosei Moriyama ◽  
Yoshinobu Asano ◽  
Kazuma Fujimoto ◽  
Takashi Okamura ◽  
Tsunefumi Shibuya ◽  
...  

1991 ◽  
Vol 15 (9) ◽  
pp. 837-846 ◽  
Author(s):  
Kensei Tobinai ◽  
Tomoko Ohtsu ◽  
Masaki Hayashi ◽  
Tomohiro Kinoshita ◽  
Yoshihiro Matsuno ◽  
...  


1994 ◽  
Vol 15 (5-6) ◽  
pp. 469-479 ◽  
Author(s):  
Koichi Ohshima ◽  
Masahiro Kikuchi ◽  
Takao Shibata ◽  
Yoshiaki Sumiyoshi ◽  
Shinichi Kobari ◽  
...  




1995 ◽  
Vol 34 (2) ◽  
pp. 118-121 ◽  
Author(s):  
Mayumi KODAMA ◽  
Hitoshi MATSUOKA ◽  
Koichi MAEDA ◽  
Muneou SUZUKI ◽  
Akihiko OKAYAMA ◽  
...  


2018 ◽  
Vol 109 (2) ◽  
pp. 221-227 ◽  
Author(s):  
Kazuharu Kamachi ◽  
Takero Shindo ◽  
Masaharu Miyahara ◽  
Kazutaka Kitaura ◽  
Michiaki Akashi ◽  
...  


2010 ◽  
Vol 41 (9) ◽  
pp. 1238-1244 ◽  
Author(s):  
Gabriela Gualco ◽  
Lawrence M. Weiss ◽  
Glen N. Barber ◽  
Carlos E. Bacchi


2017 ◽  
Vol 35 (9) ◽  
pp. 955-962 ◽  
Author(s):  
Andrea B. Moffitt ◽  
Sandeep S. Dave

In this review, we examine the genomic landscapes of lymphomas that arise from B, T, and natural killer cells. Lymphomas represent a striking spectrum of clinical behaviors. Although some lymphomas are curable with standard therapy, the majority of the affected patients succumb to their disease. Here, the genetic underpinnings of these heterogeneous entities are reviewed. We consider B-cell lymphomas, including Burkitt lymphoma, diffuse large B-cell lymphoma, Hodgkin lymphoma, and primary mediastinal B-cell lymphoma. We also examine T-cell lymphomas, including anaplastic large-cell lymphoma, angioimmunoblastic T-cell lymphoma, cutaneous T-cell lymphoma, adult T-cell leukemia/lymphoma, and other peripheral T-cell lymphomas. Together, these malignancies make up most lymphomas diagnosed around the world. Genomic technologies, including microarrays and next-generation sequencing, have enabled a better understanding of the molecular underpinnings of these cancers. We describe the broad genomics findings that characterize these lymphoma types and discuss new therapeutic opportunities that arise from these findings.



2002 ◽  
Vol 29 (11) ◽  
pp. 748-753 ◽  
Author(s):  
Hidenori Watabe ◽  
Tamihiro Kawakami ◽  
Yoshinao Soma ◽  
Takako Baba ◽  
Masako Mizoguchi


Sign in / Sign up

Export Citation Format

Share Document